How to prevent cataracts
There are some simple things you can do to lower your risk and potentially slow or delay the development of cataracts later in life.
Diabetic retinopathy occurs when high blood sugar levels damage the blood vessels in the retina of your eye. This causes the vessels to swell and leak, or close and stop the blood from passing through. These changes can blur your vision.
There are two types of diabetic retinopathy:
Diabetic retinopathy often doesn’t have symptoms in its early stages. As it gets worse, you may have the following symptoms:
Your ophthalmologist will put drops in your eye to dilate your pupils. This lets them look through a special lens to see the inside of your eye and look for:
You may also have a fluorescein angiography, in which a special dye is injected into a vein in your arm. Your ophthalmologist will take pictures with a special camera as the dye circulates through the blood vessels in your eyes.
Your treatment depends on what your ophthalmologist sees in your eyes. If you have mild or moderate non-proliferative diabetic retinopathy, you may not need treatment right away. Your ophthalmologist will check your eyes frequently to learn when you need treatment.
If you have proliferative (advanced) diabetic retinopathy, you and your doctor may decide to use the following treatments:
Diabetes affects over 34.2 million people in the United States, with diabetic retinopathy being one of the leading causes of blindness. At The Ohio State University Havener Eye Institute, it’s important to us to approach this head-on, combining state-of-the-art treatment with personalized eye care for every patient. Our retinal specialists have been trained at world-renowned institutions across the country, making our institute one of the top eye care facilities in the nation.
The Robinson Advanced Imaging Center provides our patients access to the most advanced ophthalmic imaging equipment available, including fundus photography, fluorescein angiography, spectral domain optical coherence tomography (SD-OCT) and ophthalmic sonography. All of these are critical in monitoring the progression and treatment of diabetic retinopathy.